73 related articles for article (PubMed ID: 2017158)
1. DuP 753 can antagonize the effects of angiotensin II in rat liver.
Bauer PH; Chiu AT; Garrison JC
Mol Pharmacol; 1991 Apr; 39(4):579-85. PubMed ID: 2017158
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
Crawford KW; Frey EA; Cote TE
Mol Pharmacol; 1992 Jan; 41(1):154-62. PubMed ID: 1310139
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
Cogan MG; Liu FY; Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
[TBL] [Abstract][Full Text] [Related]
4. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
[TBL] [Abstract][Full Text] [Related]
5. Subclasses of angiotensin II binding sites and their functional significance.
Dudley DT; Panek RL; Major TC; Lu GH; Bruns RF; Klinkefus BA; Hodges JC; Weishaar RE
Mol Pharmacol; 1990 Sep; 38(3):370-7. PubMed ID: 2402226
[TBL] [Abstract][Full Text] [Related]
6. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
[TBL] [Abstract][Full Text] [Related]
7. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
[TBL] [Abstract][Full Text] [Related]
9. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
Chang RS; Lotti VJ
Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
[TBL] [Abstract][Full Text] [Related]
10. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
Cobb CS; Brown JA
Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
[TBL] [Abstract][Full Text] [Related]
11. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
[TBL] [Abstract][Full Text] [Related]
12. Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists.
Leung KH; Smith RD; Pieter ; Timmermans BM; Chiu AT
Neurosci Lett; 1991 Feb; 123(1):95-8. PubMed ID: 2062460
[TBL] [Abstract][Full Text] [Related]
13. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
[TBL] [Abstract][Full Text] [Related]
14. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells.
Moreau C; Rasolonjanahary R; Audinot V; Kordon C; Enjalbert A
Mol Cell Neurosci; 1994 Dec; 5(6):597-603. PubMed ID: 7704434
[TBL] [Abstract][Full Text] [Related]
18. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177.
Sechi LA; Grady EF; Griffin CA; Kalinyak JE; Schambelan M
J Hypertens Suppl; 1991 Dec; 9(6):S224-5. PubMed ID: 1818953
[No Abstract] [Full Text] [Related]
19. Angiotensin II receptor subtypes and biological responses in the rat heart.
Feolde E; Vigne P; Frelin C
J Mol Cell Cardiol; 1993 Nov; 25(11):1359-67. PubMed ID: 8301669
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II stimulates phosphoinositide turnover and phosphorylase through AII-1 receptors in isolated rat hepatocytes.
García-Sáinz JA; Macías-Silva M
Biochem Biophys Res Commun; 1990 Oct; 172(2):780-5. PubMed ID: 2173579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
